Equity benchmarks started off the week on a positive note, backed by Infosys that gained 2.5 percent after the appointment of new CEO and MD.
The 30-share BSE Sensex rose 89.51 points to 32,922.45 and the 50-share NSE Nifty gained 23.60 points at 10,145.40. About 980 shares advanced against 291 declining shares on the BSE.
Infosys, Indiabulls Housing, Tata Motors, Dr Reddy's Labs, SBI, Aurobindo Pharma and ICICI Bank were early gainers while Tech Mahindra, Sun Pharma and Hero MotoCorp were early losers.
Biocon surged 10 percent as the US FDA approved Mylan and Biocon's Ogivri, the first biosimilar for Trastuzumab, for the Treatment of HER2-Positive breast and gastric cancers.
Syngene International, MT Educare, Zee Learn, Videocon Industries and Ashok Leyland gained up to 8 percent.
Missed call
@8817002233,WHATSAPP NO. 8602780449
Mail Us =
starindiamarket@gmail.com
No comments:
Post a Comment